Supplementary Table S4 from A Composite Low-Grade Inflammation Score and Cancer Outcomes: Results from the Moli-sani Study

Authors: Simona Costanzo, Augusto Di Castelnuovo, Marialaura Bonaccio et al.

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:p><p>Supplementary Table S4 shows the vause-specific and Fine–Gray competing-risk hazard ratios and 95% confidence intervals for cancer mortality, cancer hospitalization, and fatal and non-fatal colorectal cancer (INFLA-score Q5 versus Q1-Q4).</p></jats:p>

Keywords

cancer psupplementary table shows vausespecific

Supplementary Table S4 from A Composite Low-Grade Inflammation Score and Cancer Outcomes: Results from the Moli-sani Study

Abstract

Keywords

Related Articles

Supplementary Figure 9 from Targeting the NAD&lt;sup&gt;+&lt;/sup&gt; Salvage Pathway Blocks Metabolic Recovery and Enhances β-Lapachone Toxicity in NQO1-Expressing Glioblastoma Cells

Supplementary Figure S3 from Pharmacologic Inhibition of PMS2 Induces MMR Deficiency and Response to Immune Checkpoint Blockade

Supplementary Table S2 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies

Supplementary Table S6 from &lt;i&gt;Helicobacter pylori&lt;/i&gt; Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis

Data from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies

Supplementary Figure 9 from Targeting the NAD<sup>+</sup> Salvage Pathway Blocks Metabolic Recovery and Enhances β-Lapachone Toxicity in NQO1-Expressing Glioblastoma Cells

Supplementary Table S6 from <i>Helicobacter pylori</i> Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis